This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, ...

Here’s everything you need to know about GLP-1 agonists for weight loss including how they work, if they’re effective and who they might work for.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Overall weight loss in the obese mice following 2 weeks of GLP-1–MK-801 treatment was 20–25%; fat mass and lean mass were reduced by 45% and 8% respectively, compared with 22% and 4% following ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.